Alzheimer’s drug Lecanemab works by triggering a specific cleaning program in immune cells
New research provides evidence that the Alzheimer’s disease drug Lecanemab functions by activating a specific cleaning mechanism within the brain’s immune cells. The study indicates that the therapeutic antibody requires…